Chimin Health Management Co., Ltd.
603222.SS · SHH
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 837.24M | 386.20M | 45.97M | 34.46M | 0.07 |
| 2023 FY | 894.51M | 378.81M | -43.83M | -65.48M | -0.12 |
| 2024 FY | 775.73M | 279.60M | -63.58M | -59.71M | -0.11 |
| 2025 FY | 683.60M | 181.29M | -153.15M | -245.58M | -0.47 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 2.71B | 939.64M | 649.31M | 597.25M | 1.71B |
| 2023 FY | 2.48B | 820.13M | 251.18M | 459.83M | 1.58B |
| 2024 FY | 2.41B | 846.22M | 313.23M | 502.78M | 1.48B |
| 2025 FY | 2.31B | 999.23M | 295.28M | 727.97M | 1.22B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | 204.65M | -196.11M | 8.54M | -30.67M | 374.52M |
| 2023 FY | 140.20M | -149.22M | -9.02M | -10.74M | -398.43M |
| 2024 FY | 72.99M | -122.01M | -49.03M | -16.69M | 61.10M |
| 2025 FY | -10.35M | -46.22M | -56.57M | -19.76M | -17.95M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 4.31B | 4.25B | — | — | — |
| 2023 FY | 4.37B | 4.58B | — | — | — |
| 2024 FY | 3.69B | 3.88B | — | — | — |
| 2025 FY | 4.77B | 5.20B | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q2 | 185.43M | 43.41M | -43.71M | -39.06M | -0.07 |
| 2025 Q3 | 178.27M | 85.14M | -31.40M | -24.45M | -0.05 |
| 2025 Q4 | 141.24M | 9.62M | -110.59M | -168.43M | -0.32 |
| 2026 Q1 | 163.10M | 54.89M | -17.06M | -25.92M | -0.05 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q2 | 2.53B | 1.01B | 349.73M | 723.10M | 1.42B |
| 2025 Q3 | 2.50B | 1.01B | 335.61M | 756.58M | 1.40B |
| 2025 Q4 | 2.31B | 999.23M | 295.28M | 727.97M | 1.22B |
| 2026 Q1 | 2.27B | 1.07B | 282.19M | 787.74M | 1.11B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q2 | -70.61M | -12.20M | -82.81M | -6.76M | -249.31M |
| 2025 Q3 | 3.84M | -13.91M | -10.07M | — | -14.12M |
| 2025 Q4 | 21.90M | -4.56M | 17.34M | -4.84M | -40.33M |
| 2026 Q1 | 25.58M | -20.85M | 4.73M | -4.99M | -13.10M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q2 | 4.11B | 4.48B | — | — | — |
| 2025 Q3 | 5.89B | 6.31B | — | — | — |
| 2025 Q4 | 4.77B | 5.20B | — | — | — |
| 2026 Q1 | 4.59B | 5.10B | — | — | — |